Ozempic vs Mounjaro 2026: Which GLP-1 Wins for Weight Loss?

If you're researching weight loss medications in 2026, you've probably landed on two names that keep coming up: Ozempic and Mounjaro. Maybe your friend lost 40 pounds on one, your sister is on the other, and you're wondering which one is actually better. The truth? They're both incredibly effective, but they work a little differently—and the "best" one depends entirely on your body, your goals, and how you respond.

Let's walk through everything you need to know, in plain English, so you can have an informed conversation with your doctor.

What Are Ozempic and Mounjaro, Really?

Both Ozempic and Mounjaro are injectable medications that were originally developed for type 2 diabetes but have become widely used for weight loss. They belong to a class of drugs that mimic hormones your body naturally makes to regulate blood sugar and appetite.

Ozempic contains semaglutide, a GLP-1 receptor agonist. It mimics one hormone—GLP-1—that tells your brain you're full, slows down digestion, and helps regulate blood sugar.

Mounjaro contains tirzepatide, which is a dual-action medication. It mimics both GLP-1 and GIP, another hormone involved in insulin release and fat metabolism. Think of it as hitting two targets instead of one.

Both are taken once a week via a small subcutaneous injection (just under the skin), and both have been game-changers for people struggling with weight that hasn't budged with diet and exercise alone.

How Much Weight Can You Actually Lose?

This is the question everyone wants answered, and the clinical trial data gives us a pretty clear picture—though real-world results always vary.

In the landmark SURMOUNT trials, people taking Mounjaro lost an average of 15-22% of their body weight over 72 weeks, depending on the dose. That means someone weighing 200 pounds could lose 30-44 pounds on average.

Ozempic, in the STEP trials, led to an average weight loss of about 12-15% of body weight. For that same 200-pound person, that's roughly 24-30 pounds.

So Mounjaro edges ahead in the numbers—but here's the nuance: some people respond beautifully to Ozempic and hit those higher percentages, while others may not tolerate Mounjaro's dual action as well. Weight loss isn't just about the drug; it's about how your unique body responds, your lifestyle, your starting weight, and your consistency.

Side Effects: What to Expect

Let's be honest: both medications can cause side effects, especially in the first few weeks as your body adjusts.

The most common side effects for both are gastrointestinal: nausea, vomiting, diarrhea, constipation, and occasional heartburn. These tend to be most intense during dose increases and often improve over time.

Because Mounjaro works on two hormone pathways, some people find the nausea a bit more intense, especially at higher doses. That said, many people tolerate it beautifully—it really depends on your individual system.

Both medications also carry rare but serious risks, including pancreatitis, gallbladder issues, and thyroid concerns. Your doctor will screen you for risk factors before prescribing, and you'll be monitored throughout treatment.

One thing we hear often in our practice: starting low and going slow with dose increases makes a huge difference in tolerability. Rushing to the highest dose isn't a race—it's about finding the sweet spot where you're losing weight without feeling miserable.

How Do They Work Differently in Your Body?

Ozempic's single-hormone approach is elegant and effective. It primarily works by reducing appetite and slowing gastric emptying, which means food stays in your stomach longer and you feel fuller for longer periods.

Mounjaro's dual-hormone mechanism adds another layer. The GIP component seems to enhance fat burning and may improve how your body processes glucose and stores fat. Some research suggests this combo may be why Mounjaro leads to slightly more weight loss on average—but again, individual response varies widely.

Both drugs also help reduce cravings, particularly for high-sugar and high-fat foods. Many patients describe a quieting of food noise—that constant mental chatter about what to eat next.

Cost and Access in 2026

Here's where things get tricky. Brand-name Ozempic and Mounjaro can cost over $1,000 per month without insurance, and many insurance plans still don't cover them for weight loss alone (though coverage is improving).

Compounded versions of semaglutide and tirzepatide have become widely available and are significantly more affordable—often starting around $99-$299 per month through telehealth providers. These are made by licensed compounding pharmacies and contain the same active ingredients, though they're not FDA-approved in the same way as the brand-name versions.

If cost is a barrier—and for most people, it is—compounded options can make treatment accessible while still being prescribed and monitored by real physicians.

For Women: What You Should Know

Women tend to respond very well to both medications, though hormonal fluctuations—especially around your menstrual cycle or perimenopause—can sometimes affect how you tolerate doses or experience side effects. Nausea may be more pronounced during certain times of the month. If you're planning pregnancy, you'll need to stop these medications at least two months before trying to conceive, as their safety during pregnancy hasn't been established. Many women also report that these medications help break through weight loss plateaus that have been stubborn for years, particularly around the midsection.

For Men: What You Should Know

Men often see robust weight loss results on both medications, sometimes losing weight a bit faster than women in the first few months—likely due to higher baseline muscle mass and metabolic rate. Gastrointestinal side effects may be slightly less common in men, though this isn't universal. If you're athletic or focused on muscle retention, pairing these medications with strength training and adequate protein intake is crucial, as rapid weight loss can include some muscle loss along with fat.

Which One Should You Choose?

There's no universal "better" option. If you have type 2 diabetes or prediabetes, both work beautifully. If you're primarily focused on weight loss, Mounjaro's slightly higher average weight loss might appeal to you—but Ozempic is still incredibly effective and may be better tolerated by some.

Your doctor will consider your medical history, risk factors, tolerance for side effects, and cost constraints. Some providers start with semaglutide because there's more long-term data available, while others prefer tirzepatide's dual action for patients who need more aggressive intervention.

The most important factor? Consistency. The best medication is the one you can afford, tolerate, and stick with long-term.

From the Ozari Care Team

In our practice, we've seen excellent results with both semaglutide and tirzepatide. We typically start patients on the lowest effective dose and increase gradually based on tolerance and results—not according to a rigid schedule. Remember that these medications work best alongside nutrition and movement changes; they're powerful tools, but not magic bullets. If one medication doesn't work well for you, the other might be a better fit—everyone's body is different.

Ready to Start Your GLP-1 Journey?

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

---

Medically reviewed by the Ozari Clinical Care Team — licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 24, 2026